Actavis, Inc. News Headlines

ACT 
$217.45
*  
1.23
0.56%
Get ACT Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Wednesday's ETF with Unusual Volume: PPH
7/23/2014 2:23:30 PM - BNK Invest

ACT Gets FDA Date, CGIX Opens Wallet, DPRX Once Again Takes OneStep Forward
7/21/2014 11:06:00 PM - RTT News

Synergy Pharmaceuticals Progresses with Mid-Stage Candidate - Analyst Blog
7/18/2014 6:15:00 PM - Zacks.com

Interesting ACT Put And Call Options For December 20th
7/18/2014 10:47:17 AM - BNK Invest

Mylan (MYL) Joins the Tax-Inversion Wave - Analyst Blog
7/16/2014 1:03:00 PM - Zacks.com

Will Earnings Season Provide The Next Catalyst For Stocks?
7/14/2014 5:19:00 AM - Seeking Alpha

Synergy Pharmaceuticals' Plecanatide to Move into Phase III - Analyst Blog
7/9/2014 5:10:00 PM - Zacks.com

Actavis Confirms Generic Ampyra Patent Challenge
7/8/2014 5:52:00 PM - RTT News

InsiderInsights.com Daily Round Up: 7/7/14
7/8/2014 1:21:00 PM - Seeking Alpha

AbbVie Again Sweetens Takeover Offer For Shire
7/8/2014 9:36:00 AM - RTT News

M&A Activity Hits 7-Year Peak: Next 3 Takeover Targets - Analyst Blog
7/7/2014 12:29:50 PM - Zacks.com

Impax Acquires Generic Products from Actavis - Analyst Blog
7/3/2014 12:00:00 PM - Zacks.com

What Stocks Top Funds Are Buying Now
7/2/2014 7:09:00 PM - Investor's Business Daily

Impax Labs Acquires Two Generic Products From Actavis - Quick Facts
7/2/2014 4:27:00 PM - RTT News

Taro Pharmaceuticals: Last Week's Move Is Only The Beginning
7/2/2014 9:05:00 AM - Seeking Alpha

Actavis Closes Acquisition Of Furiex Pharma - Quick Facts
7/2/2014 9:00:00 AM - RTT News

Noteworthy ETF Inflows: SSO, ACE, ACT, ADBE
7/1/2014 10:59:18 AM - BNK Invest

Actavis Appoints Former CEO Paul Bisaro As Executive Chairman - Quick Facts
7/1/2014 9:23:00 AM - RTT News

Actavis Closes Acquisition Of Forest Labs - Quick Facts
7/1/2014 8:29:00 AM - RTT News

Wall Street Set For Firmer Open As Global Manufacturing Activity Encourages
7/1/2014 6:27:00 AM - RTT News

FTC Puts Conditions On Actavis Deal To Buy Forest Laboratories
6/30/2014 10:18:00 PM - RTT News

Sector Update: Healthcare
6/30/2014 8:37:37 AM - MT Newswires

Sector Update: Healthcare Shares Flat in Pre-Market Trade
6/30/2014 8:33:20 AM - MT Newswires

Actavis Confirms Generic Zubsolv Patent Challenge - Quick Facts
6/30/2014 7:43:00 AM - RTT News

Auxilium and QLT to Merge on Tax Saving Attractions - Analyst Blog
6/27/2014 12:10:00 PM - Zacks.com